naion glp-1 news RAs and NAION: What Clinicians Should Know | Paramesh Shamanna posted on the topic Ozempic & Wegovy Lawsuits |

Glucagon-like Peptide 1 and Atrial Natriuretic Peptide in a Female Mouse Model of Obstructive Pulmonary Disease

doi: 10.1016/j.bbagen.2013.04.004 321 LaffertyRAFlattPRIrwinN

we confirm a GLP-1 program is right for you and pick your starting medication

This conclusion was further confirmed by a more recent meta-analysis reporting that DPP-4is as a class are neutral in terms of MACEs, all-cause mortality, and HF, although saxagliptin appears associated with an increased risk of hospitalization for HF [152]

Samms, R

And because the regulatory environment around GLP-1 access is still changing, they track developments like access expansion and the approval of new oral formulations as commercially relevant intelligence rather than background news